Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 30 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 1 (1)
P 2 (2)
P 3 (2)

Trial Status

Completed10
Recruiting8
Unknown6
Active Not Recruiting3
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07201922Phase 3Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

NCT06806592Phase 3RecruitingPrimary

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT07396467Active Not Recruiting

Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis

NCT05828953Phase 2RecruitingPrimary

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

NCT06036719RecruitingPrimary

Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives

NCT04855305Phase 2CompletedPrimary

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

NCT06537934RecruitingPrimary

Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases

NCT07080125Active Not RecruitingPrimary

A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

NCT07208201Not Yet RecruitingPrimary

Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases

NCT06068647Not ApplicableRecruiting

Ultrasound and Respiratory Physiological Signals in Lung Diseases

NCT07117253Not Yet RecruitingPrimary

Interstitial Lung Diseases in Respiratory ICU

NCT00470327RecruitingPrimary

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

NCT05727852Enrolling By Invitation

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

NCT06317831RecruitingPrimary

LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease

NCT02951416Active Not Recruiting

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank

NCT02796781Phase 1CompletedPrimary

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

NCT00129701Not ApplicableCompleted

Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation

NCT05455437UnknownPrimary

Monitoring and Evaluation Study of Project ECHO for ILD

NCT02763540Not ApplicableCompleted

Pathological Comparisons of Surgical Open Lung Biopsies and Cryobiopsies in Non-IPF ILD

NCT04370158UnknownPrimary

Interstitial Lung Diseases Cohort Study in China

Scroll to load more

Research Network

Activity Timeline